7 February 2024 in PLOS Global Public Health
The global history of conflicts has revealed that infectious diseases resulting from displacement, overcrowding, healthcare collapse, destruction of critical water and sanitation infrastructure, and malnutrition can cause death rates equal or beyond those from direct violence [1]. The crisis in Gaza is no exception and has created a perfect storm for infectious disease outbreaks.
1 January 2018 in Advanced Emergency Nursing Journal
The purpose of this article is to present a discussion of immune checkpoint inhibitors (ICIs) that are relatively new, yet growing, form of cancer therapy. Immune checkpoint inhibitors increase host immune response against neoplastic cells. Strengthened immunological response increases the potential for adverse events such as life-threatening endocrinopathies. The case of a 66-year-old man with metastatic melanoma treated with nivolumab and ipilimumab presented to the emergency department with marked hyperglycemia and elevated anion gap 19 days after receiving both agents is discussed. The patient received a diagnosis of immune-mediated diabetes requiring ongoing insulin even after discontinuation of ICIs. As treatment with this class of agents expands, emergency department providers will need to become familiar with the identification of their adverse reactions to provide the proper management of care.